PMC:7195088 / 16964-17214 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"751","span":{"begin":168,"end":187},"obj":"Chemical"},{"id":"916","span":{"begin":5,"end":10},"obj":"Disease"},{"id":"917","span":{"begin":233,"end":241},"obj":"Disease"}],"attributes":[{"id":"A751","pred":"tao:has_database_id","subj":"751","obj":"MESH:C558899"},{"id":"A916","pred":"tao:has_database_id","subj":"916","obj":"MESH:D003371"},{"id":"A917","pred":"tao:has_database_id","subj":"917","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T9","span":{"begin":53,"end":57},"obj":"Body_part"},{"id":"T10","span":{"begin":115,"end":119},"obj":"Body_part"}],"attributes":[{"id":"A9","pred":"fma_id","subj":"T9","obj":"http://purl.org/sig/ont/fma/fma7195"},{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma7195"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T6","span":{"begin":53,"end":57},"obj":"Body_part"},{"id":"T7","span":{"begin":115,"end":119},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"uberon_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T20","span":{"begin":5,"end":10},"obj":"Phenotype"}],"attributes":[{"id":"A20","pred":"hp_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/HP_0012735"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T83","span":{"begin":233,"end":241},"obj":"Disease"}],"attributes":[{"id":"A83","pred":"mondo_id","subj":"T83","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T75","span":{"begin":53,"end":57},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T76","span":{"begin":53,"end":57},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"},{"id":"T77","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0001230"},{"id":"T78","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0037237"},{"id":"T79","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0050903"},{"id":"T80","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0054249"},{"id":"T81","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0054250"},{"id":"T82","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0054251"},{"id":"T83","span":{"begin":66,"end":72},"obj":"http://purl.obolibrary.org/obo/CLO_0054252"},{"id":"T84","span":{"begin":104,"end":105},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T85","span":{"begin":115,"end":119},"obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"T86","span":{"begin":115,"end":119},"obj":"http://www.ebi.ac.uk/efo/EFO_0000934"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T124","span":{"begin":98,"end":100},"obj":"Chemical"},{"id":"T126","span":{"begin":168,"end":187},"obj":"Chemical"},{"id":"T127","span":{"begin":168,"end":177},"obj":"Chemical"},{"id":"T128","span":{"begin":178,"end":187},"obj":"Chemical"}],"attributes":[{"id":"A124","pred":"chebi_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/CHEBI_16170"},{"id":"A125","pred":"chebi_id","subj":"T124","obj":"http://purl.obolibrary.org/obo/CHEBI_25195"},{"id":"A126","pred":"chebi_id","subj":"T126","obj":"http://purl.obolibrary.org/obo/CHEBI_145924"},{"id":"A127","pred":"chebi_id","subj":"T127","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A128","pred":"chebi_id","subj":"T128","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}

{"project":"LitCovid-sentences","denotations":[{"id":"T111","span":{"begin":130,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ver, cough and other symptoms relieved with improved lung CT, Spo 2 \u003e 93% or Pao 2/Fio 2 \u003e 300 mm Hg); (b) time to lung recovery.\n• Comparison of chemoprophylaxis with lopinavir/ritonavir vs. placebo in healthcare workers exposed to COVID-19. Double-"}